Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in EBS — Emergent BioSolutions Inc.

CIK 1037389 NEW YORK, NY
Back to EBS Full portfolio

Position in EBS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,725,609
+$280,419 QoQ
Shares Held
683,247
+4.1% QoQ
Ownership
1.33%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#20
of 194 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $2,242,873,379 across 49 Drug Manufacturers - Specialty & Generic names. EBS ranks #17 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 1,708,739 $925,846,052
2 NBIX
Neurocrine Biosciences Inc
 2,335,897 $393,692,080
3 ALKS
Alkermes plc.
 6,460,928 $338,552,627
4 RDY
Dr Reddys Laboratories Ltd
 7,347,028 $106,458,435
5 ZTS
Zoetis Inc.
 1,403,300 $100,841,138
6 SUPN
Supernus Pharmaceuticals, Inc.
 1,478,180 $68,750,151
7 COLL
Collegium Pharmaceutical, Inc
 1,366,549 $49,469,073
8 PCRX
Pacira BioSciences, Inc.
 1,733,801 $43,986,531

All Filings in EBS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,725,609 683,247
2026-03-31 $5,445,190 656,047
2025-12-31 $7,133,536 577,147
2025-09-30 $4,570,938 518,247
2025-06-30 $4,399,947 689,647
2025-03-31 $3,694,800 760,247
2024-12-31 $6,365,497 665,847
2024-09-30 $4,383,307 524,947
2024-06-30 $1,184,954 173,747
2024-03-31 $2,254,989 891,300
2023-12-31 $1,313,520 547,300
2022-12-31 $3,590,240 304,000
2022-09-30 $1,156,549 55,100
2022-06-30 $2,948,800 95,000
2022-03-31 $14,699,480 358,000
2020-12-31 $5,564,160 62,100
2020-09-30 $4,557,266 44,104
2020-06-30 $30,416,065 384,624
2020-03-31 $36,046,837 623,001